137 related articles for article (PubMed ID: 30303146)
1. The clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervix.
Huang ZY; Zhang S; Zhang YZ; An JH; Luo J; Liao PJ; Chen Q; Shen H
Indian J Pathol Microbiol; 2018; 61(4):549-552. PubMed ID: 30303146
[TBL] [Abstract][Full Text] [Related]
2. Ancillary p16(INK4a) adds no meaningful value to the performance of ER/PR/Vim/CEA panel in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
Yao CC; Kok LF; Lee MY; Wang PH; Wu TS; Tyan YS; Cheng YW; Kung MF; Han CP
Arch Gynecol Obstet; 2009 Sep; 280(3):405-13. PubMed ID: 19153755
[TBL] [Abstract][Full Text] [Related]
3. Differential Diagnosis between Primary Endocervical and Endometrial Adenocarcinoma using Immunohistochemical Staining of Estrogen Receptor, Vimentin, Carcinoembryonic Antigen and p16.
Yanaranop M; Ayuwat S; Nakrangsee S
J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S106-15. PubMed ID: 27266224
[TBL] [Abstract][Full Text] [Related]
4. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.
Park KJ; Kiyokawa T; Soslow RA; Lamb CA; Oliva E; Zivanovic O; Juretzka MM; Pirog EC
Am J Surg Pathol; 2011 May; 35(5):633-46. PubMed ID: 21490443
[TBL] [Abstract][Full Text] [Related]
5. Distinguishing between primary endocervical and endometrial adenocarcinomas: is a 2-marker (Vim/CEA) panel enough?
Liao CL; Hsu JD; Lee MY; Kok LF; Li YJ; Wang PH; Yao CC; Han CP
Virchows Arch; 2010 Apr; 456(4):377-86. PubMed ID: 20221633
[TBL] [Abstract][Full Text] [Related]
6. p16 INK4 and CEA can be mutually exchanged with confidence between both relevant three-marker panels (ER/Vim/CEA and ER/Vim/p16 INK4) in distinguishing primary endometrial adenocarcinomas from endocervical adenocarcinomas in a tissue microarray study.
Han CP; Lee MY; Tyan YS; Kok LF; Yao CC; Wang PH; Hsu JD; Tseng SW
Virchows Arch; 2009 Oct; 455(4):353-61. PubMed ID: 19763614
[TBL] [Abstract][Full Text] [Related]
7. Cervical adenocarcinoma: a retrospective clinicopathologic study of 16 cases.
Barbu I; Crăiţoiu S; Mărgăritescu C
Rom J Morphol Embryol; 2012; 53(3):615-24. PubMed ID: 22990556
[TBL] [Abstract][Full Text] [Related]
8. Utility of p16INK4a, CEA, Ki67, P53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions.
Liang J; Mittal KR; Wei JJ; Yee H; Chiriboga L; Shukla P
Int J Gynecol Pathol; 2007 Jan; 26(1):71-5. PubMed ID: 17197900
[TBL] [Abstract][Full Text] [Related]
9. [Value of ER, VIM, CEA and p16 detection in the diagnosis and differential diagnosis of primary endocervical and endometrial adenocarcinomas].
Hu WW; Tao JH; Li GM; Xu X; Yang XM
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):526-8, 531. PubMed ID: 20335127
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis problems in a case of minimal deviation adenocarcinoma of the cervix.
Simionescu C; Georgescu CV; Mărgăritescu C; Niculescu M
Rom J Morphol Embryol; 2006; 47(3):245-9. PubMed ID: 17308683
[TBL] [Abstract][Full Text] [Related]
11. Minimal deviation adenocarcinoma of the uterine cervix has abnormal expression of sex steroid receptors, CA125, and gastric mucin.
Toki T; Shiozawa T; Hosaka N; Ishii K; Nikaido T; Fujii S
Int J Gynecol Pathol; 1997 Apr; 16(2):111-6. PubMed ID: 9100063
[TBL] [Abstract][Full Text] [Related]
12. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
Lee S; Rose MS; Sahasrabuddhe VV; Zhao R; Duggan MA
Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764
[TBL] [Abstract][Full Text] [Related]
13. Villoglandular adenocarcinoma of the cervix: clarity is needed on the histological definition for this difficult diagnosis.
Macdonald RD; Kirwan J; Hayat K; Herrington CS; Shawki H
Gynecol Oncol; 2006 Jan; 100(1):192-4. PubMed ID: 16266744
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors influencing decisions about surgical treatment of villoglandular adenocarcinoma of the uterine cervix.
Kim HJ; Sung JH; Lee E; Ahn S; Song SY; Choi CH; Kim TJ; Kim BG; Bae DS; Lee JW
Int J Gynecol Cancer; 2014 Sep; 24(7):1299-305. PubMed ID: 24987921
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix.
Cina SJ; Richardson MS; Austin RM; Kurman RJ
Mod Pathol; 1997 Mar; 10(3):176-80. PubMed ID: 9071723
[TBL] [Abstract][Full Text] [Related]
16. Adding the p16(INK4a) marker to the traditional 3-marker (ER/Vim/CEA) panel engenders no supplemental benefit in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
Han CP; Lee MY; Kok LF; Ruan A; Wu TS; Cheng YW; Tyan YS; Lin CY
Int J Gynecol Pathol; 2009 Sep; 28(5):489-96. PubMed ID: 19696622
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of estrogen receptors, progesterone receptors, Ki-67 antigen, and human papillomavirus DNA in normal and neoplastic epithelium of the uterine cervix.
Konishi I; Fujii S; Nonogaki H; Nanbu Y; Iwai T; Mori T
Cancer; 1991 Sep; 68(6):1340-50. PubMed ID: 1651807
[TBL] [Abstract][Full Text] [Related]
18. The utility of PAX8 and IMP3 immunohistochemical stains in the differential diagnosis of benign, premalignant, and malignant endocervical glandular lesions.
Danialan R; Assaad M; Burghardt J; Newcomb P; Cartun RW; Mandavilli S
Gynecol Oncol; 2013 Aug; 130(2):383-8. PubMed ID: 23618832
[TBL] [Abstract][Full Text] [Related]
19. Clonal status and clinicopathological observation of cervical minimal deviation adenocarcinoma.
Gong L; Zhang WD; Liu XY; Han XJ; Yao L; Zhu SJ; Lan M; Li YH; Zhang W
Diagn Pathol; 2010 Apr; 5():25. PubMed ID: 20416098
[TBL] [Abstract][Full Text] [Related]
20. Is the ovarian preservation safe in young women with stages IB-IIA villoglandular adenocarcinoma of the uterine cervix?
Ju UC; Kang WD; Kim SM
J Gynecol Oncol; 2018 Jul; 29(4):e54. PubMed ID: 29770624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
